The number of PMS targets will not be arbitrarily enlarged by pharmaceutical companies

It seems that the number of targets for PMS(Post-Marketing Surveillance)-targeted pharmaceutical products will not be arbitrarily enlarged by pharmaceutical companies.

On the 22^nd, the Ministry of Food and Drug Safety gave the administrative notice of the Partial Amendment for the ‘New Drug Reevaluation Standard,’ including contents to make application for modification if the minimum number of...